Elisabeth Scholander
Direttore Tecnico/Scientifico/R&S presso Carmeda AB
Profilo
Elisabeth Scholander is currently the Vice President of Research & Development at Carmeda AB since 1991.
Prior to this, she worked as a Research Chemist at Medicarb AB.
Posizioni attive di Elisabeth Scholander
Società | Posizione | Inizio |
---|---|---|
Carmeda AB
Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Direttore Tecnico/Scientifico/R&S | 01/01/1991 |
Precedenti posizioni note di Elisabeth Scholander
Società | Posizione | Fine |
---|---|---|
Medicarb AB
Medicarb AB Pharmaceuticals: MajorHealth Technology Medicarb AB manufactures pharmaceutical products. It develops pharmaceuticals from biologically active carbohydrates and improves the performance of blood and tissue contacting medical devices with biocompatible coatings. The company was founded in 1983 and is headquartered in Bromma, Sweden. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Carmeda AB
Carmeda AB Pharmaceuticals: MajorHealth Technology Carmeda AB develops, manufactures and markets biocompatible coating technologies. Its technologies address complications such as thrombosis, inflammatory response, and infection associated with the use of medical devices. The company was founded by Karl Olov Peter Larm and Per Olsson in 1984 and is headquartered in Solna, Sweden. | Health Technology |
Medicarb AB
Medicarb AB Pharmaceuticals: MajorHealth Technology Medicarb AB manufactures pharmaceutical products. It develops pharmaceuticals from biologically active carbohydrates and improves the performance of blood and tissue contacting medical devices with biocompatible coatings. The company was founded in 1983 and is headquartered in Bromma, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Elisabeth Scholander